NZ336929A - Purified receptor that binds TRAIL and antibodies thereof - Google Patents
Purified receptor that binds TRAIL and antibodies thereofInfo
- Publication number
- NZ336929A NZ336929A NZ336929A NZ33692998A NZ336929A NZ 336929 A NZ336929 A NZ 336929A NZ 336929 A NZ336929 A NZ 336929A NZ 33692998 A NZ33692998 A NZ 33692998A NZ 336929 A NZ336929 A NZ 336929A
- Authority
- NZ
- New Zealand
- Prior art keywords
- trail
- antibodies
- expression vectors
- dna sequences
- purified receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79986197A | 1997-02-13 | 1997-02-13 | |
| US81525597A | 1997-03-12 | 1997-03-12 | |
| US82953697A | 1997-03-28 | 1997-03-28 | |
| US86985297A | 1997-06-04 | 1997-06-04 | |
| US08/883,036 US6072047A (en) | 1997-02-13 | 1997-06-26 | Receptor that binds trail |
| PCT/US1998/002239 WO1998035986A1 (en) | 1997-02-13 | 1998-02-11 | Receptor that binds trail |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ336929A true NZ336929A (en) | 2000-11-24 |
Family
ID=27542220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ336929A NZ336929A (en) | 1997-02-13 | 1998-02-11 | Purified receptor that binds TRAIL and antibodies thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6072047A (cg-RX-API-DMAC10.html) |
| EP (2) | EP1676857A3 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5031132B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE308561T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU735686B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2279838A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE69832178T3 (cg-RX-API-DMAC10.html) |
| DK (1) | DK1005488T4 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2251767T5 (cg-RX-API-DMAC10.html) |
| IL (2) | IL131030A0 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ336929A (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998035986A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020160446A1 (en) * | 2000-11-14 | 2002-10-31 | Holtzman Douglas A. | Novel genes encoding proteins having prognostic diagnostic preventive therapeutic and other uses |
| US6313269B1 (en) * | 1997-03-14 | 2001-11-06 | Smithkline Beecham Corporation | Tumor necrosis factor related receptor, TR6 |
| US20050233958A1 (en) * | 1997-03-17 | 2005-10-20 | Human Genome Sciences, Inc. | Death domain containing receptor 5 |
| US6872568B1 (en) | 1997-03-17 | 2005-03-29 | Human Genome Sciences, Inc. | Death domain containing receptor 5 antibodies |
| US20080248046A1 (en) * | 1997-03-17 | 2008-10-09 | Human Genome Sciences, Inc. | Death domain containing receptor 5 |
| US20040136951A1 (en) * | 1997-03-17 | 2004-07-15 | Human Genome Sciences, Inc. | Death domain containing receptor 5 |
| NZ508381A (en) | 1997-03-17 | 2002-09-27 | Human Genome Sciences Inc | Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5) |
| US20100152426A1 (en) * | 1997-05-15 | 2010-06-17 | Ashkenazi Avi J | Apo-2 receptor fusion proteins |
| PT981618E (pt) * | 1997-05-15 | 2007-11-23 | Genentech Inc | ''anticorpo anti-apo-2'' |
| US6342369B1 (en) * | 1997-05-15 | 2002-01-29 | Genentech, Inc. | Apo-2-receptor |
| JP2001514888A (ja) * | 1997-08-15 | 2001-09-18 | アイドゥン ファーマシューティカルズ, インコーポレイテッド | Trailレセプター、これをコードする核酸、およびその使用方法 |
| EP1012179A2 (en) * | 1997-09-12 | 2000-06-28 | Apotech R&D S.A. | Cysteine rich receptors: trail |
| WO2001060397A1 (en) | 2000-02-16 | 2001-08-23 | Genentech, Inc. | Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| PT1086138E (pt) * | 1998-06-12 | 2010-01-04 | Genentech Inc | Anticorpos monoclonais, anticorpos de reacção cruzada e método para produzir os mesmos |
| US6252050B1 (en) * | 1998-06-12 | 2001-06-26 | Genentech, Inc. | Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
| US20050281821A1 (en) * | 1999-01-06 | 2005-12-22 | Flavia Pernasetti | Method and composition for angiogenesis inhibition |
| US6627199B1 (en) | 1999-07-09 | 2003-09-30 | Amgen Inc | Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family |
| JP2003505045A (ja) * | 1999-07-16 | 2003-02-12 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | ヒト腫瘍壊死因子レセプターtr13およびtr14 |
| US6951738B2 (en) | 1999-07-16 | 2005-10-04 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptors TR13 and TR14 |
| WO2001010908A1 (en) | 1999-08-04 | 2001-02-15 | Amgen Inc. | Ntr3, a member of the tnf-receptor supergene family |
| MXPA02001264A (es) | 1999-08-04 | 2002-07-22 | Amgen Inc | Fhm, nuevo miembro de la familia de supergenes de ligando de factor de necrosis tumoral. |
| WO2001012671A1 (en) * | 1999-08-12 | 2001-02-22 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr16 |
| US20030134788A1 (en) * | 1999-08-12 | 2003-07-17 | Baker Kevin P. | Human tumor necrosis factor receptor TR16 |
| AU2006201322A1 (en) * | 1999-09-27 | 2006-04-27 | Genentech, Inc. | Methods for making recombinant proteins using apoptosis inhibitors |
| US6586206B1 (en) * | 1999-09-27 | 2003-07-01 | Genentech, Inc. | Methods for making recombinant proteins using apoptosis inhibitors |
| PT2857516T (pt) | 2000-04-11 | 2017-08-28 | Genentech Inc | Anticorpos multivalentes e utilizações dos mesmos |
| TWI318983B (en) * | 2000-05-02 | 2010-01-01 | Uab Research Foundation | An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| US7476383B2 (en) * | 2000-05-02 | 2009-01-13 | The Uab Research Foundation | Antibody selective for DR4 and uses thereof |
| US7279160B2 (en) * | 2000-05-02 | 2007-10-09 | The Uab Research Foundation | Combinations of DR5 antibodies and other therapeutic agents |
| KR100436089B1 (ko) * | 2000-07-06 | 2004-06-14 | 설대우 | 분비성 재조합 트라이머형의 트레일 단백질 생산을 위한 디엔에이 카세트, 테트라사이클린/독시사이클린-유도성아데노-관련 바이러스 벡터, 이 둘의 조합, 및 이들을이용한 유전자 치료 |
| US20040005314A1 (en) * | 2001-07-27 | 2004-01-08 | Enrique Escandon | Apo-2l receptor agonist and cpt-11 synergism |
| WO2002009755A2 (en) | 2000-07-27 | 2002-02-07 | Genentech, Inc. | Apo-2l receptor agonist and cpt-11 synergism |
| WO2002079377A2 (en) * | 2000-11-08 | 2002-10-10 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to trail receptors |
| US20060062786A1 (en) * | 2000-11-08 | 2006-03-23 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
| US20030228309A1 (en) * | 2000-11-08 | 2003-12-11 | Theodora Salcedo | Antibodies that immunospecifically bind to TRAIL receptors |
| US20030139963A1 (en) * | 2000-12-08 | 2003-07-24 | Chickering D. Maxwell | Decision theoretic approach to targeted solicitation by maximizing expected profit increases |
| US20020155109A1 (en) * | 2001-04-20 | 2002-10-24 | Lynch David H. | Bispecific antibodies that bind TRAIL-R1 and TRAIL-R2 |
| KR100932577B1 (ko) * | 2001-05-18 | 2009-12-17 | 기린 홀딩스 가부시키가이샤 | 항 trail-r 항체 |
| US7348003B2 (en) | 2001-05-25 | 2008-03-25 | Human Genome Sciences, Inc. | Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors |
| US20050214209A1 (en) * | 2001-05-25 | 2005-09-29 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
| MXPA03010747A (es) | 2001-05-25 | 2004-03-02 | Human Genome Sciences Inc | Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral. |
| US7361341B2 (en) * | 2001-05-25 | 2008-04-22 | Human Genome Sciences, Inc. | Methods of treating cancer using antibodies that immunospecifically bind to trail receptors |
| US20090226429A1 (en) * | 2001-05-25 | 2009-09-10 | Human Genome Sciences, Inc. | Antibodies That Immunospecifically Bind to TRAIL Receptors |
| US20050129616A1 (en) * | 2001-05-25 | 2005-06-16 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
| JP4509570B2 (ja) | 2001-07-03 | 2010-07-21 | ジェネンテック, インコーポレイテッド | ヒトdr4抗体及びその使用法 |
| JP2005502645A (ja) * | 2001-08-08 | 2005-01-27 | ザ ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | 細胞特異的プロモーターからの発現を増幅するための方法 |
| EP2348043A1 (en) | 2001-10-02 | 2011-07-27 | Genentech, Inc. | APO-2 ligand variants and uses thereof |
| US7741285B2 (en) | 2001-11-13 | 2010-06-22 | Genentech, Inc. | APO-2 ligand/trail formulations |
| US7842668B1 (en) | 2001-11-13 | 2010-11-30 | Genentech, Inc. | Apo-2 ligand/trail formulations |
| CA2466054C (en) | 2001-11-13 | 2012-01-03 | Genentech, Inc. | Apo-2 ligand/trail formulations |
| JP2005516958A (ja) * | 2001-12-20 | 2005-06-09 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | Trailレセプターに免疫特異的に結合する抗体 |
| WO2004001009A2 (en) | 2002-06-24 | 2003-12-31 | Genentech, Inc. | Apo-2 ligand/trail variants and uses thereof |
| WO2004085479A2 (en) * | 2003-03-26 | 2004-10-07 | Apogenix Gmbh | Treatment of viral infections |
| BRPI0509201A (pt) | 2004-03-23 | 2007-08-28 | Biogen Idec Inc | agentes de acoplamento de receptor e usos terapêuticos destes |
| ES2365719T3 (es) * | 2004-08-06 | 2011-10-10 | Genentech, Inc. | Ensayos y procedimientos que utilizan biomarcadores. |
| CN101061238B (zh) | 2004-08-06 | 2013-11-20 | 健泰科生物技术公司 | 使用生物标志的测定法和方法 |
| JP2008513367A (ja) * | 2004-09-08 | 2008-05-01 | ジェネンテック・インコーポレーテッド | デスレセプターリガンド及びcd20抗体の使用方法 |
| RU2007112952A (ru) * | 2004-09-08 | 2008-10-20 | Дженентек, Инк. (Us) | Способы применения лигандов рецепторов смерти и cd20-антител |
| JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| US8029783B2 (en) * | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
| BRPI0606791A2 (pt) | 2005-02-02 | 2010-02-09 | The Uab Research Foundation | métodos de reverter ou prevenir a resistência de uma célula a um agonista do receptor da morte, de triar uma célula quanto a um biomarcador da resistência a um agonista do receptor da morte, de monitorar a resistência a um agonista do receptor da morte em um indivìduo, de induzir seletivamente a apoptose em uma célula alvo expressando um receptor da morte, de tratar de um indivìduo com cáncer, de tratar de um indivìduo com uma doença inflamatória ou autoimune, de bloquear a ligação da proteìna contendo card a um receptor da morte em uma célula, de bloquear a associação de um iap com o receptor da morte e de triar um modulador de uma proteìna contendo card, composição, ácido nucleico isolado, vetor, célula, e, polipeptìdeo isolado |
| US20060188498A1 (en) * | 2005-02-18 | 2006-08-24 | Genentech, Inc. | Methods of using death receptor agonists and EGFR inhibitors |
| US20090155247A1 (en) * | 2005-02-18 | 2009-06-18 | Ashkenazi Avi J | Methods of Using Death Receptor Agonists and EGFR Inhibitors |
| US7629315B2 (en) * | 2005-03-09 | 2009-12-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Compositions for blocking the inhibitory effect of human CRP on human leptin |
| WO2007094842A2 (en) | 2005-12-02 | 2007-08-23 | Genentech, Inc. | Binding polypeptides and uses thereof |
| BRPI0615997A8 (pt) | 2005-08-16 | 2018-05-22 | Genentech Inc | método para prever a sensibilidade de uma amostra de célula ou tecido, método para induzir apoptose em uma amostra de célula ou tecido e método de tratamento de uma disfunção |
| CA2619654A1 (en) * | 2005-08-24 | 2007-03-01 | Cell Matrix | Combination therapies for inhibiting integrin-extracellular matrix interactions |
| CA2629306A1 (en) | 2005-11-23 | 2007-05-31 | Genentech, Inc. | Methods and compositions related to b cell assays |
| US20070218504A1 (en) * | 2006-03-09 | 2007-09-20 | University Of Pittsburgh | Human leptin-derived polypeptides and uses thereof |
| EP2379585A2 (en) * | 2008-10-10 | 2011-10-26 | Anaphore, Inc. | Polypeptides that bind trail-ri and trail-r2 |
| US20110086770A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Combinatorial Libraries Based on C-type Lectin-like Domain |
| CA2780130A1 (en) | 2009-11-05 | 2011-05-12 | The Uab Research Foundation | Treating basal-like genotype cancers |
| US8703712B2 (en) | 2010-03-18 | 2014-04-22 | The Uab Research Foundation | Targeting cancer stem cells with DR5 agonists |
| BR112013010574A2 (pt) | 2010-10-29 | 2016-08-09 | Daiichi Sankyo Co Ltd | anticorpo, fragmento funcional do anticorpo, composição farmacêutica, usos de um anticorpo ou um fragmento funcional do mesmo e de pelo menos um membro selecionado do grupo que consiste de paclitaxel, carvoplatina, cpt-11, vinblastina, e 5-fu, polinucleotídeo, vetor, célula hospedeira transformada, e, método de produzir o anticorpo |
| US20140105898A1 (en) | 2011-02-28 | 2014-04-17 | Istituto Di Ricovero E Cura A Carattere Scientific Materno-Infantile Burlo Garo | Apoptosis-inducing molecules and uses therefor |
| WO2012151317A1 (en) | 2011-05-03 | 2012-11-08 | Genentech, Inc. | Vascular disruption agents and uses thereof |
| CN102898526A (zh) * | 2011-07-28 | 2013-01-30 | 山东先声麦得津生物制药有限公司 | 一种肿瘤坏死因子相关凋亡诱导配体融合蛋白及其制备和应用 |
| ES2812208T3 (es) | 2013-03-14 | 2021-03-16 | Bristol Myers Squibb Co | Combinación de un agonista de DR5 y un antagonista de anti-PD-1 y métodos de uso |
| GB201312155D0 (en) * | 2013-07-05 | 2013-08-21 | Ucl Business Plc | Therapeutic invention |
| WO2015138638A1 (en) | 2014-03-11 | 2015-09-17 | Theraly Pharmaceuticals, Inc. | Long acting trail receptor agonists for treatment of autoimmune diseases |
| US11007251B2 (en) | 2015-12-17 | 2021-05-18 | The Johns Hopkins University | Ameliorating systemic sclerosis with death receptor agonists |
| CN109195620B (zh) | 2016-04-07 | 2022-06-28 | 约翰霍普金斯大学 | 用死亡受体激动剂治疗胰腺炎和疼痛的组合物和方法 |
| EP3323428A1 (en) | 2016-11-17 | 2018-05-23 | CNRS Centre National de la Recherche Scientifique | Selective c-flip inhibitors as anticancer agents |
| EP3910331A1 (en) | 2020-05-15 | 2021-11-17 | iOmx Therapeutics AG | Intracellular kinase associated with resistance against t-cell mediated cytotoxicity, and uses thereof |
| GB202016058D0 (en) | 2020-10-09 | 2020-11-25 | Ucl Business Ltd | Therapeautic treatment |
| EP4257132A1 (en) | 2022-04-08 | 2023-10-11 | iOmx Therapeutics AG | Sik3 inhibitors for treating diseases resistant to death receptor signalling |
| WO2024175554A1 (en) | 2023-02-21 | 2024-08-29 | Institut Curie | Trail agonists for use in the treatment of cancer in patients having an activating alteration of fgfr3 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2225378C (en) | 1995-06-29 | 2012-04-17 | Immunex Corporation | Cytokine that induces apoptosis |
| ATE362982T1 (de) | 1997-01-28 | 2007-06-15 | Human Genome Sciences Inc | ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET |
| US20010010924A1 (en) * | 1997-03-14 | 2001-08-02 | Keith Charles Deen | Tumor necrosis factor related receptor, tr6 polynecleotides |
| US6313269B1 (en) * | 1997-03-14 | 2001-11-06 | Smithkline Beecham Corporation | Tumor necrosis factor related receptor, TR6 |
| NZ508381A (en) * | 1997-03-17 | 2002-09-27 | Human Genome Sciences Inc | Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5) |
| US6872568B1 (en) * | 1997-03-17 | 2005-03-29 | Human Genome Sciences, Inc. | Death domain containing receptor 5 antibodies |
| WO1998046643A1 (en) * | 1997-04-16 | 1998-10-22 | Millennium Biotherapeutics, Inc. | TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e |
| US6342369B1 (en) * | 1997-05-15 | 2002-01-29 | Genentech, Inc. | Apo-2-receptor |
| PT981618E (pt) * | 1997-05-15 | 2007-11-23 | Genentech Inc | ''anticorpo anti-apo-2'' |
| AU8400398A (en) | 1997-07-11 | 1999-02-08 | Trustees Of The University Of Pennsylvania, The | Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use |
| JP2001514888A (ja) | 1997-08-15 | 2001-09-18 | アイドゥン ファーマシューティカルズ, インコーポレイテッド | Trailレセプター、これをコードする核酸、およびその使用方法 |
| EP1012179A2 (en) | 1997-09-12 | 2000-06-28 | Apotech R&D S.A. | Cysteine rich receptors: trail |
-
1997
- 1997-06-26 US US08/883,036 patent/US6072047A/en not_active Expired - Lifetime
-
1998
- 1998-02-11 ES ES98908474T patent/ES2251767T5/es not_active Expired - Lifetime
- 1998-02-11 CA CA002279838A patent/CA2279838A1/en not_active Abandoned
- 1998-02-11 EP EP05023483A patent/EP1676857A3/en not_active Withdrawn
- 1998-02-11 AU AU66505/98A patent/AU735686B2/en not_active Ceased
- 1998-02-11 JP JP53582098A patent/JP5031132B2/ja not_active Expired - Lifetime
- 1998-02-11 NZ NZ336929A patent/NZ336929A/xx not_active IP Right Cessation
- 1998-02-11 WO PCT/US1998/002239 patent/WO1998035986A1/en not_active Ceased
- 1998-02-11 IL IL13103098A patent/IL131030A0/xx active IP Right Grant
- 1998-02-11 DK DK98908474.4T patent/DK1005488T4/da active
- 1998-02-11 EP EP98908474A patent/EP1005488B9/en not_active Expired - Lifetime
- 1998-02-11 AT AT98908474T patent/ATE308561T1/de active
- 1998-02-11 DE DE69832178T patent/DE69832178T3/de not_active Expired - Lifetime
-
1999
- 1999-07-21 IL IL131030A patent/IL131030A/en not_active IP Right Cessation
-
2000
- 2000-03-27 US US09/536,201 patent/US6569642B1/en not_active Expired - Fee Related
- 2000-05-25 US US09/578,392 patent/US6642358B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6072047A (en) | 2000-06-06 |
| EP1005488A4 (en) | 2003-03-05 |
| DE69832178T3 (de) | 2012-03-29 |
| HK1029796A1 (en) | 2001-04-12 |
| ES2251767T3 (es) | 2006-05-01 |
| DE69832178T2 (de) | 2006-07-20 |
| JP5031132B2 (ja) | 2012-09-19 |
| EP1005488B2 (en) | 2011-12-14 |
| WO1998035986A1 (en) | 1998-08-20 |
| AU6650598A (en) | 1998-09-08 |
| US6642358B1 (en) | 2003-11-04 |
| JP2002514069A (ja) | 2002-05-14 |
| EP1005488B1 (en) | 2005-11-02 |
| DK1005488T4 (da) | 2012-01-16 |
| EP1005488A1 (en) | 2000-06-07 |
| EP1676857A3 (en) | 2007-04-04 |
| DE69832178D1 (de) | 2005-12-08 |
| EP1005488B9 (en) | 2012-04-18 |
| IL131030A (en) | 2011-02-28 |
| AU735686B2 (en) | 2001-07-12 |
| CA2279838A1 (en) | 1998-08-20 |
| ES2251767T9 (es) | 2012-10-17 |
| US6569642B1 (en) | 2003-05-27 |
| ES2251767T5 (es) | 2012-03-07 |
| EP1676857A2 (en) | 2006-07-05 |
| IL131030A0 (en) | 2001-01-28 |
| ATE308561T1 (de) | 2005-11-15 |
| DK1005488T3 (da) | 2006-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL131030A0 (en) | Receptor that binds trail | |
| NZ504548A (en) | Polypeptides and nucleic acids encoding human chordin | |
| DE69334111D1 (en) | Cd27 ligand | |
| KR960704038A (ko) | 세포 표면 수용체 Hek와 결합하는 사이토킨(Cytokines That Bind the Cell Surface Receptor Hek) | |
| IL193919A0 (en) | DcR3 POLYPEPTIDE A TNFR HOMOLOG | |
| CA2422622A1 (en) | Novel baff-r nucleic acids and polypeptides | |
| AU1846995A (en) | Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay | |
| US6114148C1 (en) | High level expression of proteins | |
| CA2312667A1 (en) | Novel cytokine | |
| EP0619839A4 (en) | Novel polypeptides for promoting cell attachment. | |
| AU4778101A (en) | Novel polypeptides, and nucleic acids encoding the same | |
| IL193886A0 (en) | Antibodies that bind to ldcam sequences | |
| ATE257160T1 (de) | Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde | |
| AU5510286A (en) | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor | |
| DK192189D0 (da) | Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid | |
| EP0992584A3 (en) | Purified mammalian FLT3 ligands and agonists and antagonists thereof | |
| AU6292694A (en) | Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof | |
| WO1996023884A3 (en) | Human peroxisome proliferator activated receptors | |
| KR940703920A (ko) | 시그날-펩타이드-유리 스태필로키나제의 발현 | |
| GB9416536D0 (en) | Orphan receptor | |
| CA2311646A1 (en) | Tsa305 gene | |
| DE69831584T2 (de) | Polypeptide mit wasserkanalaktivität und dna sequenzen | |
| YU80600A (sh) | Mutantni soj humanog hepatitis b virusa i njegova primena | |
| WO1999043834A3 (en) | P-selectin ligand protein, including tetrameric fusion proteins | |
| EP1019500A4 (en) | NEW IFN RECEPTOR 1 BINDING PROTEINS, ENCODING DNA AND METHOD FOR REGULATING THE CELLULAR RESPONSE TO INTERFERON |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| EXPY | Patent expired |